XML 117 R40.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2023
Equity [Abstract]  
Schedule of Stock Based Compensation Expense Total share-based compensation expense is reported in “General and administrative expenses” in the accompanying consolidated statements of income, and summarized below.
Year Ended December 31,
202320222021
(In millions)
Pretax
Charges
Net-of-Tax
Amount
Pretax
Charges
Net-of-Tax
Amount
Pretax
Charges
Net-of-Tax
Amount
RSAs and PSUs (defined below)$108 $102 $97 $90 $66 $62 
Employee stock purchase plan and stock options
Total$115 $109 $103 $96 $72 $68 
Schedule of Restricted and Performance Stock Activity Activity for stock-based awards in the year ended December 31, 2023, is summarized below.
RSAsWeighted
Average
Grant Date
Fair Value
PSUsWeighted
Average
Grant Date
Fair Value
Unvested balance, December 31, 2022
511,105 $237.10 312,830 $193.09 
Granted294,604 277.37 470,284 233.50 
Vested(224,269)210.22 (328,998)124.98 
Forfeited(45,993)261.71 (43,742)261.01 
Unvested balance, December 31, 2023
535,447 $268.41 410,374 $286.77 
Schedule of Stock Options, Activity
The total fair value of awards vested is presented in the following table.
Year Ended December 31,
202320222021
(In millions)
RSAs$62 $70 $53 
PSUs90 69 71 
Total vested$152 $139 $124 
Stock option activity for the year ended December 31, 2023, is summarized below.
Number of SharesWeighted Average Exercise PriceAggregate Intrinsic ValueWeighted Average Remaining Contractual term
(Per share)(In millions)(Years)
Stock options outstanding as of December 31, 2022
5,000 $33.02 
Exercised(5,000)33.02 
Stock options outstanding, vested, and exercisable as of December 31, 2023
— — $— 0.0